{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT02902757",
            "orgStudyIdInfo": {
                "id": "15-000409"
            },
            "secondaryIdInfos": [
                {
                    "id": "NCI-2016-00583",
                    "type": "REGISTRY",
                    "domain": "CTRP (Clinical Trial Reporting Program)"
                },
                {
                    "id": "15-000409",
                    "type": "OTHER",
                    "domain": "UCLA / Jonsson Comprehensive Cancer Center"
                }
            ],
            "organization": {
                "fullName": "Jonsson Comprehensive Cancer Center",
                "class": "OTHER"
            },
            "briefTitle": "FDG PET/CT in Monitoring Very Early Therapy Response in Patients With Glioblastoma",
            "officialTitle": "Very Early Response Monitoring in Patients With Glioblastoma Undergoing Therapy Using FDG PET/CT",
            "therapeuticArea": [
                "Other"
            ],
            "study": "fdg-pet-ct-in-monitoring-very-early-therapy-response-in-patients-with-glioblastoma"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-11",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2015-08-25",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-08-25",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-08-25",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2016-09-12",
            "studyFirstSubmitQcDate": "2016-09-12",
            "studyFirstPostDateStruct": {
                "date": "2016-09-16",
                "type": "ESTIMATED"
            },
            "lastUpdateSubmitDate": "2023-11-30",
            "lastUpdatePostDateStruct": {
                "date": "2023-12-04",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Jonsson Comprehensive Cancer Center",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Cancer Institute (NCI)",
                    "class": "NIH"
                },
                {
                    "name": "National Institutes of Health (NIH)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false
        },
        "descriptionModule": {
            "briefSummary": "This pilot clinical trial studies fluordeoxyglucose (fludeoxyglucose) F-18 (FDG) positron emission tomography (PET)/computed tomography (CT) in monitoring very early therapy response in patients with glioblastoma. Diagnostic procedures, such as FDG PET/CT, may help measure a patient's response to earlier treatment. Chemotherapy can induce very rapid changes to the tumor's glucose consumption which can be measured with imaging. FDG PET/CT shortly after the start of therapy may help identify very early therapy response in patients with glioblastoma.",
            "detailedDescription": "PRIMARY OBJECTIVES:\n\nI. To assess very early response to therapy in glioblastoma patients using 18F-FDG PET/CT.\n\nII. Evaluate very early changes in FDG uptake within 48 hours of start of therapy and correlate them with objective response parameters such as Response Assessment in Neuro-Oncology (RANO) and survival.\n\nOUTLINE:\n\nPatients undergo standard FDG PET/CT scan 6-8 weeks before start of chemotherapy and one additional FDG PET/CT scan within 48 hours of the start of chemotherapy."
        },
        "conditionsModule": {
            "conditions": [
                "Glioblastoma"
            ],
            "keywords": [
                "FDG",
                "PET/CT very early response (48 hrs)"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "DIAGNOSTIC",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 50,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Treatment (FDG PET/CT)",
                    "type": "EXPERIMENTAL",
                    "description": "Patients undergo standard FDG PET/CT scan 6-8 weeks before start of chemotherapy and one additional FDG PET/CT scan within 48 hours of the start of chemotherapy.",
                    "interventionNames": [
                        "Procedure: Computed Tomography",
                        "Radiation: Fludeoxyglucose F-18",
                        "Procedure: Positron Emission Tomography"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "PROCEDURE",
                    "name": "Computed Tomography",
                    "description": "Undergo FDG PET/CT",
                    "armGroupLabels": [
                        "Treatment (FDG PET/CT)"
                    ],
                    "otherNames": [
                        "CAT",
                        "CAT Scan",
                        "Computerized Axial Tomography",
                        "Computerized Tomography",
                        "CT",
                        "CT SCAN",
                        "tomography"
                    ]
                },
                {
                    "type": "RADIATION",
                    "name": "Fludeoxyglucose F-18",
                    "description": "Undergo FDG PET/CT",
                    "armGroupLabels": [
                        "Treatment (FDG PET/CT)"
                    ],
                    "otherNames": [
                        "18FDG",
                        "FDG",
                        "fludeoxyglucose F 18",
                        "Fludeoxyglucose F18",
                        "Fluorine-18 2-Fluoro-2-deoxy-D-Glucose",
                        "Fluorodeoxyglucose F18"
                    ]
                },
                {
                    "type": "PROCEDURE",
                    "name": "Positron Emission Tomography",
                    "description": "Undergo FDG PET/CT",
                    "armGroupLabels": [
                        "Treatment (FDG PET/CT)"
                    ],
                    "otherNames": [
                        "Medical Imaging, Positron Emission Tomography",
                        "PET",
                        "PET SCAN",
                        "Positron Emission Tomography Scan",
                        "Positron-Emission Tomography",
                        "proton magnetic resonance spectroscopic imaging"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Changes in glucose uptake",
                    "description": "Standardized uptake values (SUV) will be calculated for different organs and for regions of tumor. Further, regional target to background count-activity ratios will be established.",
                    "timeFrame": "From baseline up to 48 hours"
                },
                {
                    "measure": "Very early changes in tumor glucose uptake predictive for objective treatments response and survival assessed using RANO criteria",
                    "description": "SUV will be calculated for different organs and for regions of tumor. Further, regional target to background count-activity ratios will be established.",
                    "timeFrame": "One PET/CT 48 hours after start of therapy"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with histologically proven high grade glioma\n* Intention to start therapy\n\nExclusion Criteria:\n\n* Severe psychiatric illness\n* Inability to give written consent\n* Breast feeding / pregnancy",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "99 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Soosan Roodbari",
                    "role": "CONTACT",
                    "phone": "310 794-1596",
                    "email": "sroodbari@mednet.ucla.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Johannes Czernin, MD",
                    "affiliation": "UCLA / Jonsson Comprehensive Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "UCLA / Jonsson Comprehensive Cancer Center",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90095",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Soosan Roodbari",
                            "role": "CONTACT",
                            "phone": "310-794-1596",
                            "email": "sroodbari@mednet.ucla.edu"
                        },
                        {
                            "name": "Johannes Czernin, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000005909",
                    "term": "Glioblastoma"
                }
            ],
            "ancestors": [
                {
                    "id": "D000001254",
                    "term": "Astrocytoma"
                },
                {
                    "id": "D000005910",
                    "term": "Glioma"
                },
                {
                    "id": "D000018302",
                    "term": "Neoplasms, Neuroepithelial"
                },
                {
                    "id": "D000017599",
                    "term": "Neuroectodermal Tumors"
                },
                {
                    "id": "D000009373",
                    "term": "Neoplasms, Germ Cell and Embryonal"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009380",
                    "term": "Neoplasms, Nerve Tissue"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9019",
                    "name": "Glioblastoma",
                    "asFound": "Glioblastoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4561",
                    "name": "Astrocytoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M9020",
                    "name": "Glioma",
                    "relevance": "LOW"
                },
                {
                    "id": "M20446",
                    "name": "Neoplasms, Neuroepithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M19845",
                    "name": "Neuroectodermal Tumors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20388",
                    "name": "Neuroectodermal Tumors, Primitive",
                    "relevance": "LOW"
                },
                {
                    "id": "M12318",
                    "name": "Neoplasms, Germ Cell and Embryonal",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12325",
                    "name": "Neoplasms, Nerve Tissue",
                    "relevance": "LOW"
                },
                {
                    "id": "T2518",
                    "name": "Glioblastoma",
                    "asFound": "Glioblastoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T2519",
                    "name": "Glioma",
                    "relevance": "LOW"
                },
                {
                    "id": "T4092",
                    "name": "Neuroepithelioma",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003847",
                    "term": "Deoxyglucose"
                },
                {
                    "id": "D000019788",
                    "term": "Fluorodeoxyglucose F18"
                }
            ],
            "ancestors": [
                {
                    "id": "D000019275",
                    "term": "Radiopharmaceuticals"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000963",
                    "term": "Antimetabolites"
                },
                {
                    "id": "D000000998",
                    "term": "Antiviral Agents"
                },
                {
                    "id": "D000000890",
                    "term": "Anti-Infective Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21686",
                    "name": "Fluorodeoxyglucose F18",
                    "asFound": "One year",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7043",
                    "name": "Deoxyglucose",
                    "asFound": "Cytomegalovirus",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8587",
                    "name": "Fluorides",
                    "relevance": "LOW"
                },
                {
                    "id": "M21258",
                    "name": "Radiopharmaceuticals",
                    "relevance": "LOW"
                },
                {
                    "id": "M4281",
                    "name": "Antimetabolites",
                    "relevance": "LOW"
                },
                {
                    "id": "M4314",
                    "name": "Antiviral Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4214",
                    "name": "Anti-Infective Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                }
            ]
        }
    },
    "hasResults": false
}